Polyurethanes and Their Applications in Cardiovascular Surgery: A Review

Document Type : Original Article

Authors

1 PhD in Medical Engineering, Faculty of Engineering, Isfahan University

2 Assistant Professor, Department of Biomedical Engineering, Shahrekord branch, Islamic Azad University, Shahrekord, Iran

3 Senior Expert in Biomaterial, Nanotechnology and Tissue Engineering group, Faculty of Advanced Medical Technologies, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract
Polyurethanes are a diverse family of polymers that hold a significant position in the medical industry. Their applications are extensive; however, it is important to recognize that polyurethanes are particularly well-suited for manufacturing devices tailored to specific applications. Accordingly, this overview highlights selected applications, focusing on specific processes, debated findings, and potential avenues for future development, though it is not exhaustive.
Cardiac surgeons' equipment demonstrates that polyurethanes play no significant role in intra-aortic balloons, blood bags for ventricular assist devices (VADs), catheters, and pacemaker leads, which are considered the most important components. Testing of polyurethanes as blood vessel substitutes remains incomplete due to their lack of long-term resistance to degradation. Breast implants covered with polyurethane foam continue to be a subject of scientific debate. Although the use of polyurethane is limited, these materials have interesting properties. Additionally, cardiac dressings and tissue engineering scaffolds offer promising avenues for new developments.

Keywords


 
 
1. Chen J, Wei J, Chang C et al. Studies on segmented polyurethane for biomedical application: Effects of composition and hard-segment content on biocompatibility. J Biomed Mater Res 1998;
41: 633-648.
2. Griesser HJ. Degradation of polyurethanes in biomedical applications - A review. Polymer
Degra-dation and Stability 1991; 33: 329-354.
3. Zhang D, Gracias D, Ward R et al. Surface studies of polymer blends by sum frequency vibra-tional spectroscopy, atomic force microscopy, and contact angle goniometry. J Phys Chem B 1998;
102: 6225-6230.
4. Lamba NMK, Woodhouse KA, Cooper SL. Polyurethanes in Biomedical Applications. Boca Raton: CRC Press, 1998.
5. Gunatillake PA, Meijs GF, McCarthy SJ et al. Synthesis and biostability of a novel
silox-ane-polyurethane elastomer. 25th Annual Meeting of the Society for Biomaterials. Rhode Island, USA 1999; Vol XXII: 369.
6. Rhodes NP, Shortland AP, Hunt J et al. In vivo biostability of polyurethanes purported to be biologically stable. 25th Annual Meeting of the Society for Biomaterials. Rhode Island, USA 1999; Vol XXII: 62.
7. Szycher M. Szychers Handbook of Polyurethanes. Boca Raton: CRC Press, 1999.
8. Rusu, L-C.; Ardelean, L.C.; Jitariu, A.-A.; Miu,
C.A.; Streian, C.G. An Insight into the
Structural Diversity and Clinical Applicability of Polyurethanes in Biomedicine. Polymers 2020, 12, 1197.
9. Jiang, C., Zhang, L., Yang, Q. et al. Self-healing polyurethane-elastomer with mechanical tunability for multiple biomedical applications in vivo. Nat Commun 12, 4395 (2021).
10.   Wu L, Weisberg DM, Runt J et al. An
investigation of the in vivo stability of poly (ether urethane urea) blood sacs. J Biomed Mater Res 1999; 44: 371-380.
11.   Fare S, Petrini P, Motta A et al. Synergistic effects of oxidative environments and mechanical stress on in vitro stability of Polyether urethanes and Polycarbonate urethanes. J Biomed Mater Res 1999; 45: 62-74.
12.   Cadogan DF. Plasticizers: health aspects. In: Pritchard G, ed. Plastics Additives: An A-Z
Refer-ence. London: Chapman & Hall, 1998:
505-512.
13.   Vermette P, Wang GB, Santerre JP
et al. Commercial polyurethanes: the potential influence of auxil- airy chemicals on the biodegradation process. J Biomatter Sci Polymer Eden 1999; 10: 729-749.
14.   Bernacca GM, Gulbransen MJ, Wilkinson
R et al. In vitro blood compatibility of surface-modified polyurethanes. Biomaterials 1998; 19: 1151-1165.
15.   Phaneuf MD, Snyder M, Berceli SA et al. Covalent linkage of recombinant hirudin to a novel ionic poly(carbonate) urethane polymer with protein binding sites: Determination of surface anti thrombin activity. Artif Organs 1998; 22: 657-665.
16.   Han, M., Chen, L., Aras, K.
et al. Catheter-integrated soft multilayer electronic arrays for multiplexed sensing and actuation during cardiac surgery. Nat Biomed Eng 4, 997–1009 (2020).
17.   Hord, E.C., Bolch, C.M., Tuzun, E. et al. Evaluation of the Corin nova Heart Assist Device in an Acute Heart Failure Model. J. of Cardiovasc. Trans. Res. 12, 155–163 (2019).
18.   Vermette P, Wang GB, Santerre JP et al. Commercial polyurethanes: The potential
influence of auxiliary chemicals on the biodegradation process. J Biomatter Sci Polymer Eden 1999; 10: 729-749.
19.   Faré S, Petrini P, Motta A et al. Synergistic effects of oxidative environments and mechanical stress on the in vitro stability of poly-ether-urethanes and
poly-carbonate-urethanes. J Biomed Mater Res 1999;
45: 62-74.
20.   Tang YW, Santerre JO, Labow RS. Biostability of polycarbonate polyurethanes with different hard segment size and chemistry. 24th Annual Meeting of the Society for Biomaterials. San Diego, USA,
1998: 371.
21.   Flemming RG, Proctor RA, Cooper SL. Bacterial adhesion to functionalized polyurethanes. J Biomater Sci Polym Edn 1999; 10: 679-697.
22.    Gengenbach TR, Griesser HJ. Deposition conditions influence the post-deposition oxidation of methyl methacrylate plasma polymer films. J
Polymer Sci Pt A: Polymer Chem 1998; 36:
985-1000.
23.   McFarland CD, Jenkins M, Griesser HJ et al. Albumin-binding surfaces: synthesis and
character- ization. J Biomatter Sci Polymer Eden 1998; 9: 1207-1225.
24.   McLean KM, McArthur SL, Chatelier RC et al. Hybrid biomaterials: surface-MALDI mass
spec- trometry analysis of covalent binding versus physisorption of proteins. Coll Surf B: Bio-interfaces 2000; in press.
25.   Kingshott P, StJohn HAW, Griesser HJ. Identification of proteins adsorbed on synthetic materials by MALDI mass spectrometry. Anal Biochem 1999; 273: 156-162.
26.   Gengenbach TR, Griesser HJ. Aging of
1, 3-diaminopropane plasma deposited polymer films: Mechanisms and reaction pathways. J Polymer Sci Pt A: Polymer Chem 1999; 37: 2191-2206.
27.   Ahluwalia A, Basta G, Ricci D et al.
Langmuir-Blodgett films of antibodies as mediators of endothelial cell adhesion on polyurethanes. J Biomatter Sci Polymer Eden 1999; 10:
295-304.
28.   Kingshott P, Griesser HJ. Surfaces that resist
bio adhesion. Curr Opinion in Solid State & Mater Sci 1999; 4: 403-412.
29.   Österberg E, Bergström K, Holmberg K et al. Protein-rejecting ability of surface-bound
dextran in end-on and side-on configurations: comparison to PEG. J Biomed Mater Res 1995; 29: 741-747.
30.   Kingshott P, Chabrecek P, Griesser HJ. PEO
graft density controls protein adsorption. Trans
of the American Society for Biomaterials 1999; 22: 242.
31.   Yang JM, Huang MJ, Yeh TS. Preparation of poly (acrylic acid) modified polyurethane membrane for biomaterial by UV radiation without degassing. J Biomed Mater Res 1999; 45: 133-139.
32.   Casas J, Zhao Q, Donovan M et al. In vitro modulation of macrophage phenotype and inhibition of polymer degradation by dexamethasone in a human macrophage/Fe/stress system. J Biomed Mater Res 1999; 46: 475-484.
33.   Kingshott P, StJohn HA, Chatelier RC et al. Matrix-assisted laser desorption ionization mass spectrometry detection of proteins adsorbed in vivo onto contact lenses. J Biomed Mater Res
2000; 49: 36-42.
34.   Bolooki, H. Historical background. In: Bolooki H, ed. Clinical Application of the Intra-Aortic Balloon Pump Armonk. New York: Futura Publishing Co. Inc., 1998: 65-71.
35.   Jeschke MG, Hermanutz V, Wolf SE et al. Polyurethane vascular prostheses decrease neointimal formation compared with expanded polytetrafluoroethylene. J Vasc Surg 1999;
29: 168-176.
36.   Antonelli D, Rosenfeld T, Freedberg NA et al. Insulation lead failure: It is a matter of insulation coating, venous approach, or both? PACE
1998; 21: 418-421.
37.   Gammage MD, Krabb HJ, Moquet B et al. Experience with a lead fixation/suture sleeve. PACE 1998; 21: 549-552.
38.   Tatgumi E, Masuzawa T, Nakamura M et al. In vivo evaluation of the national cardiovascular center electrohydraulic total artificial Heart. Artif Organs 1999; 23: 242-248.
39.   Lamba NMK, Woodhouse KA, Cooper SL. Polyurethanes in Biomedical Applications. Boca Raton: CRC Press, 1998: 220-248.
40.   Kollenberg OL. Protocols for treatment of pressure ulcers. Wound Care Institute, Inc., http:// woundcare.org/newsvol2n1/ar14.htm. 1999; 1-4.
41.   Pulido-Duque JM, Reyes R, Carreira JM et al. Treatment of complete and partial obstruction of the nasolacrimal system with polyurethane stents: Initial experience. Cardiovasc Intervent Radiol
 1998; 21: 41-44.
42.   F. Oveissi a d, S. Naficy a d, A. Lee a b c, D.S. Winlaw b c, F. Dehghani a. Materials and manufacturing perspectives in engineering heart valves: a review. 2020
43.   Pathum Chandika a, Seong-Yeong Heo a, Tae-Hee Kim a, Gun-Woo Oh a, Geun-Hyeong Kim a,
Min-Sung Kim a, Won-Kyo Jung a b. Recent advances in biological macromolecule-based
tissue-engineered composite scaffolds for cardiac tissue regeneration applications. 2020
44.   Daniel E. Heath 1, Scott A. Guelcher 2, Stuart L. Cooper 1. Polyurethanes. 2020
45.   Sophie Wendels, Luc Avérous. Biobased polyurethanes for biomedical applications.
2021
46.   Buddy D. Ratner, Guigen Zhang. A History of Biomaterials. 2020
47.   Monika Bil a, Ewa Kijeńska-Gawrońska a,
Eliza Głodkowska-Mrówka b, Aneta
Manda-Handzlik c, Piotr Mrówka d. Design
and in vitro evaluation of electrospun shape
memory polyurethanes for self-fitting
tissue engineering grafts and drug delivery systems. 2020.
48.   Zahra Eivazi Zadeh a, Atefeh Solouk a, Mehdi Shafieian a, Masoumeh Haghbin Nazarpak b. Electrospun polyurethane/carbon nanotube composites with different amounts of carbon nanotubes and almost the same fiber diameter for biomedical applications. 2021
49.   Price JM, Rosenberg ES. The war against junk science: the use of expert panels in complex
medical-legal scientific litigation. Biomaterials
1998; 19: 1425-1432.
50.   Biomaterials Access Assurance Act of 1998. Public Law, USA. 13 August 1998: 105-230.
51.   Greene RJ. The Biomaterials Crisis: Part II, Biomaterials Forum, Spring 1999: 6-10.
52.   Cui, M., Chai, Z., Lu, Y., Zhu, J., & Chen, J. Developments of polyurethane in biomedical applications: A review. Resources Chemicals and Materials, 2023: 2(4), 262-276.
53.   Das, K. K., Mishra Tiwari, R., Shankar, O.,
Maiti, P., & Dubey, A. K. Tissue-engineered vascular grafts for cardiovascular disease management: Current strategies, challenges, and future perspectives. MedComm-Biomaterials and Applications, 2024.
54.   Fathi-Karkan, S., Banimohamad-Shotorbani, B., Saghati, S., Rahbarghazi, R., & Davaran, S.
A critical review of fibrous polyurethane-based vascular tissue engineering scaffolds.
Journal of Biological Engineering 2022 16: 1, 16 (1), 1-18.
55.   Kaur, R., Singh, P., Tanwar, S., Varshney, G., & Yadav, S. Assessment of Bio-Based Polyurethanes: Perspective on Applications and Bio-Degradation. Macromol 2022
56.   Navas-Gómez, K., & Valero, M. F.Why Polyurethanes Have Been Used in the Manufacture and Design of Cardiovascular Devices:
A Systematic Review. 2020
57.   Shokrollahi, P., Omidi, Y., Cubeddu,
L. X., & Omidian, H.Conductive
polymers for cardiac tissue engineering and regeneration.